CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang
    DOI: https://doi.org/10.3350/cmh.2019.0006

Excel Download

Elbasvir/grazoprevir
Reactions Weekly. 2019;1740(1):138-138   Crossref logo
Link1 Link2 Link3

Tu1504 – Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 1 Infection Receiving Dialysis
Gastroenterology. 2019;156(6):S-1346   Crossref logo
Link1 Link2

Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China
Clinical Drug Investigation. 2018;38(11):1031-1039   Crossref logo
Link1 Link2 Link3

FRI-248-Cost-effectiveness of elbasvir/grazoprevir (EBR/GZR) for treatment-naive (TN) patients with chronic hepatitis C virus (HCV) genotype 1b (GT1b) infection in Russia
Journal of Hepatology. 2019;70(1):e503-e504   Crossref logo
Link1 Link2

The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis
Journal of Viral Hepatitis. 2019;26(3):329-336   Crossref logo
Link1 Link2

Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection
Value in Health. 2017;20(8):1110-1120   Crossref logo
Link1 Link2

The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China
Value in Health. 2018;21:S65   Crossref logo
Link1 Link2

Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France
PLOS ONE. 2018;13(3):e0194329   Crossref logo
Link1

Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States
Journal of Viral Hepatitis. 2016;24(4):268-279   Crossref logo
Link1 Link2 Link3

Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam
Journal of Infection and Public Health. 2019;12(4):502-508   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.